LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 1097 | 975 | 3769 | 0.2587 | -0.0457 |
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 1097 | 1091 | 3769 | 0.2894 | -0.0023 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 1097 | 821 | 3769 | 0.2178 | -0.1034 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 1097 | 950 | 3769 | 0.2520 | -0.0551 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 1097 | 903 | 3769 | 0.2396 | -0.0727 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1097 | 387 | 3769 | 0.1027 | -0.2658 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1097 | 468 | 3769 | 0.1242 | -0.2355 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1097 | 568 | 3769 | 0.1507 | -0.1981 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1097 | 456 | 3769 | 0.1210 | -0.2400 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1097 | 558 | 3769 | 0.1480 | -0.2018 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1097 | 529 | 3769 | 0.1403 | -0.2127 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1097 | 3351 | 3769 | 0.8890 | 0.8434 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1097 | 3467 | 3769 | 0.9197 | 0.8868 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1097 | 3557 | 3769 | 0.9436 | 0.9205 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1097 | 483 | 3769 | 0.1281 | -0.2299 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1097 | 499 | 3769 | 0.1324 | -0.2239 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1097 | 493 | 3769 | 0.1308 | -0.2261 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 1 | F20 | 72 | hr | 1097 | 1955 | 3769 | 0.5186 | 0.3210 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 2 | F20 | 72 | hr | 1097 | 2065 | 3769 | 0.5478 | 0.3621 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 3 | F20 | 72 | hr | 1097 | 1997 | 3769 | 0.5298 | 0.3367 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 1 | B14 | 72 | hr | 1097 | 1070 | 3769 | 0.2839 | -0.0102 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 2 | B14 | 72 | hr | 1097 | 1021 | 3769 | 0.2709 | -0.0285 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 3 | B14 | 72 | hr | 1097 | 885 | 3769 | 0.2348 | -0.0794 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 1 | B08 | 72 | hr | 1097 | 1706 | 3769 | 0.4526 | 0.2278 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 2 | B08 | 72 | hr | 1097 | 1768 | 3769 | 0.4690 | 0.2510 |